Advances in drug resistance mechanisms of multiple myeloma: reports from the 55th ASH annual meeting / 白血病·淋巴瘤

ABSTRACT

Multiple myloma represents the second most common blood cancer.Although new drugs emerge rapidly,multiple myeloma is still incurable.Drug resistance is one of the main causes of myeloma recurrence and relapse.In this paper,advances about the drug resistance mechanisms reported in the 55th ASH annual meeting are summarized.